Sanofi (SAN) - Strategic SWOT Analysis Review

March 2018 | 73 pages | ID: S14D6208A65EN
GlobalData

Abstracts

Sanofi (SAN) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Sanofi is a healthcare company, which focuses on researching, developing, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. The major products of the company include Aubagio, Lantus, Lovenox, Plavix and others. Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals and supplements. It has operations across Europe, the Americas, Asia-Pacific, Africa and the Middle East. Sanofi is headquartered in Paris, France.

Sanofi Key Recent Developments

Mar 15,2018: Sanofi Successfully Prices EUR 8 Billion Of Bond Issues
Mar 06,2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
Feb 07,2018: Sanofi Delivers 2017 Business EPS in line with Guidance
Jan 30,2018: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
Jan 19,2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Sanofi - Key Facts
Sanofi - Key Employees
Sanofi - Key Employee Biographies
Sanofi - Major Products and Services
Sanofi - History
Sanofi - Company Statement
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sanofi - Business Description
Business Segment: Consumer Health
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Vaccines
Overview
Performance
Key Stats
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Sanofi - Corporate Strategy
Sanofi - SWOT Analysis
SWOT Analysis - Overview
Sanofi - Strengths
Sanofi - Weaknesses
Sanofi - Opportunities
Sanofi - Threats
Sanofi - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sanofi, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 15, 2018: Sanofi Successfully Prices EUR 8 Billion Of Bond Issues
Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
Jan 30, 2018: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
Jan 08, 2018: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi
Jan 08, 2018: APEIRON and Evotec Achieve First Milestone in Immuno-Oncology Alliance With Sanofi
Dec 13, 2017: Sanofi presents R&D strategy and innovative pipeline
Dec 12, 2017: Striving to Defeat Dengue with Effective Vaccines
Dec 05, 2017: Sanofi and IBM Watson Health real-world analysis showed that individuals not achieving control on basal insulin within 12 months

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sanofi, Key Facts
Sanofi, Key Employees
Sanofi, Key Employee Biographies
Sanofi, Major Products and Services
Sanofi, History
Sanofi, Subsidiaries
Sanofi, Joint Venture
Sanofi, Key Competitors
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sanofi, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Qiagen Marseille SA
Boehringer Ingelheim GmbH
Durata Therapeutics Inc
Sophiris Bio Inc
GlaxoSmithKline Plc
Novo Nordisk AS
Eli Lilly and Co
Bristol-Myers Squibb Co
AstraZeneca Plc
NewLink Genetics Corp
Merck & Co Inc
Receptos Inc
Novartis AG
F. Hoffmann-La Roche Ltd
Heska Corp
Groupe SOLACTIS SAS
Cardiome Pharma Corp